Upon treatment with ABT-263, the level of Mcl-1 increased dramatically in all HCC cell lines, but the levels of Bcl-2 and Bcl-xL did not change significantly (Figure 1B). The gene discussed is BCL2L1; the disease is hepatocellular carcinoma.